 |
Tacrolimus granules for oral suspension |
|---|---|
| Trade Name | |
| Orphan Indication | Prevention of rejection in kidney, liver or heart transplant in pediatric patients |
| USA Market Approval | USA |
| USA Designation Date | 2016-10-04 00:00:00 |
| Sponsor | Astellas Pharma Global Development, Inc.;1 Astellas Way;Northbrook, Illinois, 60062 |
